DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Tubaro A, Batista JE, Nitti VW. et al.
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.
Therapeutic advances in urology 2017;
9: 137-154
We do not assume any responsibility for the contents of the web pages of other providers.